Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva

被引:43
作者
Kaplan, Frederick S.
Fiori, Jennifer
De la Pena, Lourdes Serrano
Ahn, Jaimo
Billings, Paul C.
Shore, Eileen M.
机构
[1] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA
来源
SKELETAL DEVELOPMENT AND REMODELING IN HEALTH, DISEASE, AND AGING | 2006年 / 1068卷
关键词
fibrodysplasia ossificans progressiva; BMP-4;
D O I
10.1196/annals.1346.008
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Identification of gene mutations in Mendelian disorders is often determined by linkage analysis and positional cloning, an approach that is difficult for fibrodysplasia ossificans progressiva (FOP) due to a low reproductive fitness that results in a small number of multigenerational families showing inheritance of the disease. Altered signaling pathways can be investigated as a complementary method to identify the consequences of the mutated gene responsible for FOP and to identify potential therapeutic targets. Candidate signaling pathways for FOP are those that malfunctioning could account for the malformation of the great toes during embryonic development and could explain the postnatal progressive heterotopic endochondral ossification. Signaling pathways that fit these criteria are the BMP signaling pathway and its interacting pathways. A large body of data suggest that the BMP-4 signaling pathway is dysregulated in FOP.
引用
收藏
页码:54 / 65
页数:12
相关论文
共 44 条
[1]
Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis [J].
Ahn, J ;
de la Peña, LS ;
Shore, EM ;
Kaplan, FS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2003, 85A (04) :667-674
[2]
Smads as transcriptional co-modulators [J].
Attisano, L ;
Wrana, JL .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :235-243
[3]
Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton [J].
Brunet, LJ ;
McMahon, JA ;
McMahon, AP ;
Harland, RM .
SCIENCE, 1998, 280 (5368) :1455-1457
[4]
Bone morphogenetic proteins, their antagonists, and the skeleton [J].
Canalis, E ;
Economides, AN ;
Gazzerro, E .
ENDOCRINE REVIEWS, 2003, 24 (02) :218-235
[5]
THE NATURAL-HISTORY OF HETEROTOPIC OSSIFICATION IN PATIENTS WHO HAVE FIBRODYSPLASIA OSSIFICANS PROGRESSIVA - A STUDY OF 44 PATIENTS [J].
COHEN, RB ;
HAHN, GV ;
TABAS, JA ;
PEEPER, J ;
LEVITZ, CL ;
SANDO, A ;
SANDO, N ;
ZASLOFF, M ;
KAPLAN, FS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1993, 75A (02) :215-219
[6]
Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA [J].
de la Peña, LS ;
Billings, PC ;
Fiori, JL ;
Ahn, J ;
Kaplan, FS ;
Shore, EM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) :1168-1176
[7]
Smad-dependent and Smad-independent pathways in TGF-β family signalling [J].
Derynck, R ;
Zhang, YE .
NATURE, 2003, 425 (6958) :577-584
[8]
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover [J].
Di Guglielmo, GM ;
Le Roy, C ;
Goodfellow, AF ;
Wrana, JL .
NATURE CELL BIOLOGY, 2003, 5 (05) :410-421
[9]
Heteromeric and homomeric transforming growth factor-β receptors show distinct signaling and endocytic responses in epithelial cells [J].
Dore, JJE ;
Edens, M ;
Garamszegi, N ;
Leof, EB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :31770-31777
[10]
Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4 [J].
Dunn, NR ;
Winnier, GE ;
Hargett, LK ;
Schrick, JJ ;
Fogo, AB ;
Hogan, BLM .
DEVELOPMENTAL BIOLOGY, 1997, 188 (02) :235-247